A major criticism of the wild-type ID8 tumor line is that it does not harbor any pathogenic mutations commonly seen in human HGSC (e.g., mutations in Tp53 [166], Brca1 or Brca2 [21,22,23] genes). This evidence concerns the gene TP53 and neoplasm.